In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

AN Irish dad with terminal cancer has called on the Government to fund lifesaving cancer treatments instead of expensive bike ...

Following mixed study results, the partners have backed away from seeking broad clearance of dato-dxd in lung cancer and ...

Glioblastoma (GBM) is the most common kind of malignant brain tumor in adults. In recent years, the tumor microenvironment ...

Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic ...

U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid ...

A new study provides more evidence that GLP-1 RAs don’t raise the risk for pancreatic cancer and may in fact offer some protection.

Other smoking cessation treatments offered by the NHS include nicotine replacement therapies such as nicotine patches or gum ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

Officials say it could help over 85,000 people give up smoking annually over the next five years, as well as prevent up to ...